Concepedia

Publication | Open Access

Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study

141

Citations

23

References

2014

Year

Abstract

ClinicalTrials.gov: NCT00265083.

References

YearCitations

Page 1